These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24316393)

  • 1. Increased plasma high-sensitivity C-reactive protein and myeloperoxidase levels may predict ischemia during myocardial perfusion imaging in slow coronary flow.
    Yurtdaş M; Yaylali YT; Kaya Y; Ozdemir M
    Arch Med Res; 2014 Jan; 45(1):63-9. PubMed ID: 24316393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow.
    Li JJ; Qin XW; Li ZC; Zeng HS; Gao Z; Xu B; Zhang CY; Li J
    Clin Chim Acta; 2007 Oct; 385(1-2):43-7. PubMed ID: 17706955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
    Kimak E; Zięba B; Duma D; Solski J
    Lipids Health Dis; 2018 Apr; 17(1):71. PubMed ID: 29618370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cut-off value for interleukin-34 as an additional potential inflammatory biomarker for estimation of slow coronary flow risk.
    Karasu M; Bolayır HA
    BMC Cardiovasc Disord; 2024 Jan; 24(1):2. PubMed ID: 38166811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased neopterin levels and its association with angiographic variables in patients with slow coronary flow: an observational study.
    Varol E; Gülcan M; Aylak F; Ozaydın M; Sütçü R; Erdoğan D; Doğan A
    Anadolu Kardiyol Derg; 2011 Dec; 11(8):692-7. PubMed ID: 22088857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon.
    Evrengul H; Tanriverdi H; Enli Y; Kuru O; Seleci D; Bastemir M; Kilic A; Kaftan A; Kilic M
    Cardiology; 2007; 108(3):186-92. PubMed ID: 17085937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation of thrombolysis in myocardial infarction frame count with insulin resistance in patients with slow coronary flow.
    Ozcan T; Gen R; Akbay E; Horoz M; Akcay B; Genctoy G; Muslu N; Camsari A; Cicek D; Gok E; Kiykim A
    Coron Artery Dis; 2008 Dec; 19(8):591-5. PubMed ID: 19005294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of risk factors and left ventricular function in patients with slow coronary flow.
    Li Y; Wang Y; Jia D; Lv Y; Zhang Y; Guan Z; Ma C
    Heart Vessels; 2016 Mar; 31(3):288-97. PubMed ID: 25475386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
    Tang WH; Wu Y; Nicholls SJ; Hazen SL
    Clin Chem; 2011 Jan; 57(1):33-9. PubMed ID: 21059827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure.
    Tang WH; Shrestha K; Troughton RW; Borowski AG; Klein AL
    Congest Heart Fail; 2011; 17(3):105-9. PubMed ID: 21609382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of endothelial dysfunction and inflammation on slow coronary flow.
    Arı H; Arı S; Erdoğan E; Tiryakioğlu O; Huysal K; Koca V; Bozat T
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):327-33. PubMed ID: 21200102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery.
    Ucar HI; Tok M; Atalar E; Dogan OF; Oc M; Farsak B; Guvener M; Yilmaz M; Dogan R; Demircin M; Pasaoglu I
    Heart Surg Forum; 2007; 10(2):E131-5. PubMed ID: 17597037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma interleukin-27 levels in patients with coronary artery disease.
    Miura K; Saita E; Suzuki-Sugihara N; Miyata K; Ikemura N; Ohmori R; Ikegami Y; Kishimoto Y; Kondo K; Momiyama Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8260. PubMed ID: 29068992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation.
    Canpolat U; Çetin EH; Cetin S; Aydin S; Akboga MK; Yayla C; Turak O; Aras D; Aydogdu S
    Clin Appl Thromb Hemost; 2016 Jul; 22(5):476-82. PubMed ID: 26139836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
    Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M
    Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of adrenergic activity in slow coronary flow and its relationship to TIMI frame count.
    Yazici M; Demircan S; Durna K; Sahin M
    Angiology; 2007; 58(4):393-400. PubMed ID: 17652227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can biomarkers help us to understand the pathogenesis of coronary slow flow? Endocan and omentin-I in slow coronary flow phenomenon].
    Sığırcı S; Sarıkaya R; Keskin K; Yıldız SS; Pilten Güzel S; Çetinkal G; Önur İ; Kılıçkesmez KO
    Turk Kardiyol Dern Ars; 2019 Jun; 47(4):251-257. PubMed ID: 31219439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High sensitive troponin-I in patients with slow coronary flow pattern.
    Erturk M; Caglar FN; Surgit O; Akturk IF; Somuncu U; Akgul O; Kurtar A; Isiksacan N; Caglar IM; Uslu N
    Kardiol Pol; 2013; 71(12):1245-50. PubMed ID: 24399583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum YKL-40 is increased in patients with slow coronary flow.
    Xu Y; Meng HL; Su YM; Chen C; Huang YH; Li XF; Fan MK; Yan YJ; Wu J; Jiang MH; Pan M
    Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.